Acknowledging that the COVID-19 outbreak has demonstrated “the resilience of the European generic medicines industry which was able to massively scale up supply to address demand surges,” off-patent industry association Medicines for Europe has suggested that Europe should now “apply the lessons from COVID-19” as it pursues its pharmaceutical strategy roadmap.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?